3/18
08:13 am
bctx
BriaCell to Present Positive Clinical Data for Bria-IMT™ and Preclinical Data for Next Generation Bria-OTS+™ Personalized Immunotherapy at the 2026 AACR Conference [Yahoo! Finance]
Medium
Report
BriaCell to Present Positive Clinical Data for Bria-IMT™ and Preclinical Data for Next Generation Bria-OTS+™ Personalized Immunotherapy at the 2026 AACR Conference [Yahoo! Finance]
3/18
07:30 am
bctx
BriaCell to Present Positive Clinical Data for Bria-IMT™ and Preclinical Data for Next Generation Bria-OTS+™ Personalized Immunotherapy at the 2026 AACR Conference
Medium
Report
BriaCell to Present Positive Clinical Data for Bria-IMT™ and Preclinical Data for Next Generation Bria-OTS+™ Personalized Immunotherapy at the 2026 AACR Conference
3/10
08:04 am
bctx
BriaCell to Present Four Poster Presentations at the 2026 AACR Annual Meeting [Yahoo! Finance]
Low
Report
BriaCell to Present Four Poster Presentations at the 2026 AACR Annual Meeting [Yahoo! Finance]
3/10
07:30 am
bctx
BriaCell to Present Four Poster Presentations at the 2026 AACR Annual Meeting
Low
Report
BriaCell to Present Four Poster Presentations at the 2026 AACR Annual Meeting
3/5
05:28 pm
bctx
BriaCell Therapeutics Corp. Announces Results of Shareholder Meeting [Canadian Business Journal (Canada)]
Medium
Report
BriaCell Therapeutics Corp. Announces Results of Shareholder Meeting [Canadian Business Journal (Canada)]
3/5
04:04 pm
bctx
BriaCell Therapeutics Corp. Announces Results of Shareholder Meeting
Medium
Report
BriaCell Therapeutics Corp. Announces Results of Shareholder Meeting
2/18
05:30 pm
bctx
BriaCell and BriaPro Enter Into Asset Purchase Agreement for Exclusive Soluble CD80 License
Neutral
Report
BriaCell and BriaPro Enter Into Asset Purchase Agreement for Exclusive Soluble CD80 License
2/17
07:30 am
bctx
BriaCell Receives Positive Recommendation from Data Safety Monitoring Board (DSMB) for Phase 3 Study in Metastatic Breast Cancer
Medium
Report
BriaCell Receives Positive Recommendation from Data Safety Monitoring Board (DSMB) for Phase 3 Study in Metastatic Breast Cancer
1/28
07:47 am
bctx
BriaCell Patients' Images Show Regression and Resolution of Metastasized Tumors and Immune Activation [Yahoo! Finance]
Medium
Report
BriaCell Patients' Images Show Regression and Resolution of Metastasized Tumors and Immune Activation [Yahoo! Finance]
1/28
07:30 am
bctx
BriaCell Patients’ Images Show Regression and Resolution of Metastasized Tumors and Immune Activation
Medium
Report
BriaCell Patients’ Images Show Regression and Resolution of Metastasized Tumors and Immune Activation
1/27
07:30 am
bctx
BriaCell Highlights Extended >18-47 Months Survival in Phase 2 Metastatic Breast Cancer Patients
Low
Report
BriaCell Highlights Extended >18-47 Months Survival in Phase 2 Metastatic Breast Cancer Patients
1/15
04:05 pm
bctx
BriaCell Therapeutics Announces Closing of US$30 million Public Offering
Medium
Report
BriaCell Therapeutics Announces Closing of US$30 million Public Offering
1/14
01:38 am
bctx
BrianCell Therapeutics drops 10%, prices $30M offering at $5.59 per unit [Seeking Alpha]
High
Report
BrianCell Therapeutics drops 10%, prices $30M offering at $5.59 per unit [Seeking Alpha]
1/13
09:00 pm
bctx
BriaCell Therapeutics Announces Pricing of $30 million Public Offering
High
Report
BriaCell Therapeutics Announces Pricing of $30 million Public Offering
1/7
10:32 am
bctx
How $594B in Precision Tech is Cracking the Metastatic Cancer Code
Low
Report
How $594B in Precision Tech is Cracking the Metastatic Cancer Code